Report Descriptions:

The Global Single-use Bioprocessing Market was estimated at USD 36.13 billion in 2026 and is projected to reach USD 158.58 billion by 2035, reflecting a robust CAGR of 15.94% over the forecast period from 2026 to 2035. The Single-use Bioprocessing market report offers a comprehensive and nuanced view of the industry, moving beyond conventional analysis. It provides a thorough examination of the markets dynamics, encompassing a detailed exploration of the factors propelling growth, such as evolving economic conditions, advancements in technology, shifts in regulatory policies, and changes in consumer behavior. Furthermore, the report discusses the projected Compound Annual Growth Rate (CAGR), providing stakeholders with a clear understanding of the market's expected growth trajectory and offering data-driven insights into future market dynamics.

The Single-use Bioprocessing market under analysis is characterized by dynamic growth and evolving trends that are reshaping the competitive landscape. With 2025 serving as the base year for this Single-use Bioprocessing market study, recent data highlights a significant expansion driven by technological advancements, rising consumer demand, and a growing focus on innovation. Companies are refining their go-to-market (GTM) strategies to effectively capture these emerging opportunities and respond to the rapidly changing market dynamics.

Key trends influencing the Single-use Bioprocessing market include the rapid adoption of digital technologies, the integration of sustainable practices, and the increasing importance of customer experience. These trends are not only driving growth but also creating new challenges for industry participants, who must adapt their GTM strategies to navigate regulatory changes, supply chain disruptions, and fluctuating economic conditions. Despite these challenges, the Single-use Bioprocessing market is poised for sustained growth, with emerging markets playing a critical role in the expansion of the industry.

Looking ahead, the Single-use Bioprocessing market is forecasted to continue its upward momentum through 2035, supported by ongoing investments in research and development, strategic partnerships, and mergers and acquisitions. Companies that can effectively tailor their GTM strategies to the evolving market landscape, innovate, and meet shifting consumer demands are likely to achieve sustained success. Single-use Bioprocessing market report provides a comprehensive analysis of the current market environment and offers valuable insights into the key drivers, challenges, and opportunities that will shape the industry's future over the next decade. This report offers a comprehensive analysis of market dynamics across various segments, regions, and countries, incorporating both qualitative and quantitative data. It covers the period from 2017 to 2035, providing a detailed examination of historical performance, current market conditions, and future projections.

Historical Analysis (2017-2024): The report presents a thorough review of market trends, performance metrics, and growth trajectories for the years 2017 through 2024. This historical perspective is crucial for understanding past market behavior and identifying patterns that influence current and future market dynamics.

Forecast and Projections (2026-2035) : Building on historical data, the report provides forward-looking insights, including market forecasts and growth projections from 2026 to 2035. It details anticipated market trends, emerging opportunities, and potential challenges across different segments, regions, and countries.

Compound Annual Growth Rate (CAGR): The report includes a precise calculation of the compound annual growth rate (CAGR) for the forecast period of 2026 to 2035. This metric will be instrumental in assessing the expected growth trajectory and the overall market potential during the forecast period.

Single-use Bioprocessing Market

What is the Single-use Bioprocessing Market

The single-use bioprocessing market refers to the global industry focused on manufacturing and supplying disposable technologies used in biopharmaceutical production. These systems include single-use bioreactors, bags, tubing, mixers, connectors, sampling systems, and filtration units that are designed for one-time use before disposal.

Unlike traditional stainless-steel systems, single-use technologies (SUTs) eliminate the need for cleaning and sterilization, thereby offering advantages in terms of operational flexibility, contamination risk reduction, cost-efficiency, and speed-to-market. The market caters primarily to biologics manufacturers, contract development and manufacturing organizations (CDMOs), vaccine producers, and research institutions. With increasing production of monoclonal antibodies, cell and gene therapies, and pandemic-response vaccines, the demand for modular, scalable, and sterile single-use platforms continues to rise across the globe.

What are the drivers of Single-use Bioprocessing

• Accelerating global demand for biologics, including monoclonal antibodies, recombinant proteins, and viral vector-based therapies.
• Single-use systems enable faster batch changeovers, reduce cleaning validation time, and enhance sterility assurance, making them ideal for multi-product facilities and clinical trial production.
• Rise of personalized medicine, cell and gene therapy, and smaller batch manufacturing drives the need for flexible, scalable single-use technologies.
• Cost savings in facility infrastructure and operational expenditure by reducing clean-in-place (CIP) and steam-in-place (SIP) requirements.
• Increased demand during the COVID-19 pandemic highlighted the value of single-use bioprocessing for rapid vaccine development and manufacturing scalability.
• Ongoing investments in decentralized production models and CDMO capacity further propel market growth.

What are the challenges and restraining factors of Single-use Bioprocessing

• Extractables and leachables (E&L) risk from plastic components can affect product quality and regulatory compliance.
• Scalability for large-volume commercial production (>2,000 L bioreactors) remains limited due to technical and economic barriers.
• Environmental sustainability concerns and waste management challenges related to disposable equipment.
• Supply chain reliability risks and lack of raw material standardization can delay production.
• Regional regulatory variations and lack of harmonized quality standards complicate global adoption and validation.

What are the regional trends of Single-use Bioprocessing

North America: Leads due to high biologics production capacity, early adoption of bioprocessing innovations, and a strong CDMO presence, driven by favorable FDA regulations and capital investment climate.

Europe: Germany, Switzerland, and the U.K. emerge as key biomanufacturing hubs, supported by EU-backed projects and national investments accelerating the shift from stainless steel to single-use systems.

Asia Pacific: Rapid growth fueled by expanding biologics pipelines, government-supported bioclusters, and cost-competitive CDMOs, especially in China, India, and South Korea.

Latin America: Growing adoption in vaccine and biologics manufacturing facilities in Brazil and Mexico, though challenged by capital investment and expertise gaps.

Middle East & Africa: Emerging interest with investments in pharmaceutical localization and modular biomanufacturing, led by UAE, Saudi Arabia, and South Africa.

Country-Wise Outlook

• United States: Market leader with extensive biomanufacturing infrastructure, robust biologics pipeline, and mature CDMO ecosystem. Federal programs like BARDA and Operation Warp Speed emphasize disposables for pandemic response, accelerating adoption.
• Germany: Key adopter of hybrid production facilities combining stainless steel and single-use technologies, with strong engineering, regulatory clarity, and supportive EU funding.
• Japan: Investing in single-use technologies for precision medicine and regenerative therapies, focusing on compact, closed systems and regulatory alignment with PMDA standards.

Competitive Analysis

The single-use bioprocessing market is moderately consolidated, with competition driven by innovations in material science, system integration, and end-to-end platform capabilities.

• Companies differentiate through product reliability, modular design, automation compatibility, and customer support.
• Focus on closed-system designs, sterility assurance, and customizable configurations to meet evolving bioproduction needs.
• Strategic partnerships with CDMOs, biopharma clients, and regulatory bodies enable better alignment with GMP and validation requirements.
• Emerging players target niche biologics segments, while established firms expand portfolios with sensor-integrated bags, AI-enabled control, and sustainable materials.
• Offering vertically integrated systems from upstream bioreactors to downstream purification and localized supply chains is a competitive advantage.
• Regulatory readiness, training services, and global distribution define market leadership.

Key players in the market include Thermo Fisher Scientific, Sartorius AG, GE Healthcare Life Sciences, Danaher Corporation, Merck KGaA, Pall Corporation, Eppendorf AG, Repligen Corporation, Corning Incorporated, Tosoh Corporation, Parker Hannifin Corporation, Cytiva, West Pharmaceutical Services, Inc., Nova Biomedical Corporation, Celltainer Bio, and others.

Recent Developments

• September 2024: Merck introduced a new single-use reactor designed to streamline and accelerate antibody-drug conjugate (ADC) manufacturing with enhanced operational efficiency and production capacity.
• March 2025: Cytiva expanded its Xcellerex X-platform by adding 500-liter and 2,000-liter bioreactor options, improving scalability and delivering up to 70% greater efficiency compared to traditional stainless steel or glass-based systems.

Study Period for the Single-use Bioprocessing Market:

Single-use Bioprocessing Market

Report Highlights:

Our team of experienced researchers has meticulously gathered and analyzed data to deliver a thorough examination of market dynamics, competitive landscape, and emerging technologies. With a focus on delivering actionable intelligence, this report aims to empower decision-makers with the information needed to make informed choices and stay ahead of the competition. Whether you are a seasoned industry player or a new entrant, our market research report serves as a strategic tool to navigate the complexities of the market, aiding in successful business planning and growth strategies.

Key Chapters of our Single-use Bioprocessing Market Report includes:

Market Dynamics, Variables, and Industry Analysis:

This chapter of our Single-use Bioprocessing market report provides an in-depth examination of the factors shaping the industry landscape. This section typically encompasses several key elements to offer a comprehensive understanding of the industry landscape such as market drivers & restraints analysis, market opportunities & trend analysis, market size & growth analysis, competitive analysis, SWOT analysis, business environment tools such as Porter's five forces & PESTEL analysis, Ansoff Matrix analysis, penetration & growth prospect analysis, regulatory framework & reimbursement scenario analysis, impact of macro & micro economic factors analysis such as Covid-19 impact, GDP growth, market inflation, U.S.- China trade war, Russia-Ukraine war impact, and supply chain analysis.

Segment Analysis & Forecast to 2035:

The segment analysis chapter of Single-use Bioprocessing market report is a critical section that delves into a detailed examination of the market's various segments. Segmentation involves dividing the market into distinct categories based on certain criteria to better understand and address the diverse needs of consumers. This chapter typically follows the introduction and provides a more granular view of the market, offering valuable insights for businesses and stakeholders. The components of the chapter lude segment definitions to understand the inclusions and exclusions of the study, assumptions, market size estimates and growth trend analysis of each segment, qualitative analysis of the segment, technological advancements, market penetration rate, market adoption rate, market share examination by each segment, segment growth drivers and restraint barriers, consumer behaviour and challenge analysis.

Regional Market Analysis & Forecast to 2035:

The chapter in Single-use Bioprocessing market research report is a pivotal section that examines and predicts the market dynamics and trends specific to different geographical regions. This chapter is crucial for businesses and stakeholders seeking a comprehensive understanding of how the market behaves across various locations, enabling them to tailor strategies and make informed decisions based on regional variations. The regional analysis chapter of our Single-use Bioprocessing market report is classified into regions & country-level. The chapter consists of North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).

Single-use Bioprocessing Market

Competitive Analysis & Company Profiles:

This section of a Single-use Bioprocessing market report is a crucial segment that provides a comprehensive overview of the competitive landscape within the market. This section is vital for businesses, investors, and stakeholders seeking insights into key players, their market positioning, strengths, weaknesses, strategies, and potential impacts on the overall market dynamics. The chapter includes research methodology used to analyse the market competition, list of key players operating in the market, detailed company profile section which includes company overview, business verticals, financial performance, product/services benchmarking, geographical presence, and strategic initiatives.

Key Players Operating in the Single-use Bioprocessing Market are as follows:

• Thermo Fisher Scientific
• Sartorius AG
• GE Healthcare Life Sciences
• Danaher Corporation
• Merck KGaA
• Pall Corporation
• Eppendorf AG
• Repligen Corporation
• Corning Incorporated
• Tosoh Corporation
• Parker Hannifin Corporation
• Cytiva
• West Pharmaceutical Services, Inc.
• Nova Biomedical Corporation
• Celltainer Bio

Single-use Bioprocessing Market

Report Scope:

Quintile Reports has segmented the Single-use Bioprocessing market into the following segments:

Based on Device, the Single-use Bioprocessing market is segmented into:

• Endovascular Devices [Balloon Angioplasty Devices
• Atherectomy Systems
• Stents (Self-Expanding Stents
• Balloon-Expandable Stents
• Covered Stent Grafts
• Bifurcated Aortic Stent Grafts)]
• Surgical Devices

Based on Procedure, the Single-use Bioprocessing market is segmented into:

• Endovascular Procedures (Balloon Angioplasty
• Primary Stenting
• Kissing Stents
• Covered Stent Grafts
• Endovascular Aortic Repair (EVAR))
• Hybrid Procedures
• Open Surgical Procedures

Based on Treatment, the Single-use Bioprocessing market is segmented into:

• Endovascular Treatment
• Surgical Treatment

Based on Patient, the Single-use Bioprocessing market is segmented into:

• Acute
• Chronic

Based on End Use, the Single-use Bioprocessing market is segmented into:

• Hospitals
• Outpatient Facilities
• Others

Report Scope	Details
Report Version	2025
Growth Rate	CAGR of 15.94 from 2026 to 2035
Base year	2025
Actual estimates/Historical data	2017 - 2024
Forecast period	2026 - 2035
Quantitative units	Revenue in USD million/billion & CAGR from 2026 to 2035
Country scope	North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).
The Segment covered by Device	Endovascular Devices [Balloon Angioplasty Devices Atherectomy Systems Stents (Self-Expanding Stents Balloon-Expandable Stents Covered Stent Grafts Bifurcated Aortic Stent Grafts)] Surgical Devices
The Segment covered by Procedure	Endovascular Procedures (Balloon Angioplasty Primary Stenting Kissing Stents Covered Stent Grafts Endovascular Aortic Repair (EVAR)) Hybrid Procedures Open Surgical Procedures
Companies covered	Thermo Fisher Scientific Sartorius AG GE Healthcare Life Sciences Danaher Corporation Merck KGaA Pall Corporation Eppendorf AG Repligen Corporation Corning Incorporated Tosoh Corporation Parker Hannifin Corporation Cytiva West Pharmaceutical Services, Inc. Nova Biomedical Corporation Celltainer Bio
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Free customization scope (equivalent to 5 analyst working days)	If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of the customization

Key Reasons to Acquire the Single-use Bioprocessing Market Research Report:

• This report offers a comprehensive analysis of the Single-use Bioprocessing market from 2017 to 2035, including market segments, current trends, estimations, and dynamics
• It also provides information on key drivers, restraints, and opportunities
• Porter's five forces analysis is used to assess the potency of buyers and suppliers, helping stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network
• The report includes an in-depth analysis of the Single-use Bioprocessing market segmentation to identify prevailing market opportunities
• Major countries in each region are mapped according to their revenue contribution to the global market
• Market player positioning is also analyzed to facilitate benchmarking and provide a clear understanding of the present position of the market players
• The report includes an analysis of the regional and global Single-use Bioprocessing market trends, key players, market segments, application areas, and market growth strategies

Single-use Bioprocessing Market

Available Customizations:

With the given market data, Quintile Reports offers customizations according to the company's specific needs. The following customization options are available for the report:

• You may ask for a global, regional, or country-specific report.
• You may ask if there are any particular types, applications, or products on which you would like to focus.
• You may ask for specific competitors/players to be profiled.

Single-use Bioprocessing Market Report

Statistics for the 2025 Single-use Bioprocessing market share, size, and revenue growth rate were created by Quintile Report™. Single-use Bioprocessing analysis includes a market forecast outlook for 2035 and a historical overview. Get a free PDF sample of this market analysis, please get in touch with our principal analyst at sales@quintilereports.com